Follow-up appointments: These will allow for ongoing assessment of your response to sitagliptin
* Correspondence: Bing He, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Archived from the original on December 22, 2015
Rights and permissions About this article Cite this article Franois, H., Mariette, X
The individual components (methionine, inositol, choline, cyanocobalamin) are FDA-recognized substances, but the combined formulation is not an FDA-approved drug product